Sanofi (SNY) — research page

US · us-cm-kg/NASDAQ/SNY · as of 2026-11-08

Identity and listing

The issuer is Sanofi, listed on NASDAQ under ticker SNY, with ISIN US80105N1054 and LEI 549300E9PC51EN656011. Its security type is recorded as non-operating entity type (other), its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is France. Its segment is not on the record. Its listing status is listed, not halted.

The disclosure read

The record holds 72 filings in the window 2025-11-08 to 2026-11-08, across 58 filing days. Of these, 44 are results, 19 are regulatory filings, 5 are takeover filings and 4 are directors' dealings. The median gap between filing days is 5 days. The latest filing is dated 2026-11-05, is of type regulatory filing, and is 3 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days, across 4359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days, across 526 issuers.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The issuer is listed, not halted.

Orderability

The outcome is not determinable under the rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 27 research houses: AlphaValue, Banco Sabadell, Barclays, Berenberg, Bernstein Société Générale, BNP Paribas Exane, Citi, Deutsche Bank, Goldman Sachs, Guggenheim, HSBC, Intesa Sanpaolo, Intron, Jefferies, J.P. Morgan, Kepler Cheuvreux, Leerink Partners, Morgan Stanley, Morningstar, Oddo BHF, RBC, Santander, TD Cowen, UBS, Wolfe, Bernstein and Société Générale.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The record holds the issuer's sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001121404.json (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://mcp.us-cm-kg.ai/events/NASDAQ/SNY (the disclosure lines)

10.6

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.7

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.8

https://www.sanofi.com/en/investors/sanofi-share-and-adrs/analyst-coverage (coverage)

10.9

https://mcp.us-cm-kg.ai/record/NASDAQ/SNY (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US80105N1054"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:ceb14b33febcdb2d.